Patent ID: 7390830

Claim:
A method for treatment of (nephropathy) or multiple sclerosis comprising administering to a subject an effective amount of at least one compound represented by the following formula (I), pharmaceutically acceptable acid addition salts thereof or pharmaceutically acceptable C 1 -C 6 alkyl addition salts thereof as an active ingredient, wherein R 1 is a phenyl group, or an indolyl group; the phenyl group or the indolyl group in the above R 1 is optionally substituted with an optional number of halogen atoms or C 1 -C 6 alkyl groups; R 2 is a hydrogen atom; j is 0; k is 1 or 2; m is 2; n is 0 or 1; R 3 is a hydrogen atom; R 4 is a hydrogen atom; R 5 is a hydrogen atom; p is 0; q is 0; G is a group represented by —NH—CO—; R 6 is a phenyl group; the phenyl group, in the above R 6 is optionally substituted with an optional number of halogen atoms, C 1 -C 6 alkyl groups, C 1 -C 6 alkoxyl groups, or amino groups; wherein the C 1 -C 6 alkyl groups or the C 1 -C 6 alkoxyl groups may further be substituted with 1 to 3 halogen atoms.